FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma

Table 2 Association between HDAC3 and FOXA1 expression and pathological features

Features	Cases	HDAC3 H-score	P value	FOXA1 H-score	P value
Pathological type
Serous	90	246.88 ± 48.12	0.06	244.82 ± 44.54	0.356
Mucinous	7	192.31 ± 43.64		186.29 ± 59.14
Clear cell	21	199.83 ± 57.52		208.89 ± 48.28
Endometrioid	9	239.98 ± 40.04		236.12 ± 71.95
FIGO stage
I–II	44	200.93 ± 54.42	0.007	202.55 ± 56.26	< 0.001
III–IV	83	253.98 ± 41.30	0.007	252.01 ± 38.24	< 0.001
Lymphatic metastasis
No	80	224.83 ± 41.34	0.002	222.98 ± 55.20	0.001
Yes	47	253.95 ± 38.06	0.002	255.12 ± 34.60	0.001
Relapse
Yes	61	263.89 ± 31.91	< 0.001	249.53 ± 42.76	0.002
No	66	209.46 ± 54.51	< 0.001	221.33 ± 54.27	0.002
DOD
Yes	43	266.52 ± 33.34	< 0.001	260.43 ± 32.87	< 0.001
No	84	219.78 ± 53.70	< 0.001	221.79 ± 53.60	< 0.001

ISSN: 1479-5876